Literature DB >> 15045135

Contribution of PAR-1, PAR-4 and GPIbalpha in intracellular signaling leading to the cleavage of the beta3 cytoplasmic domain during thrombin-induced platelet aggregation.

Christophe Dubois1, Beat Steiner, Sylvie C Meyer Reigner.   

Abstract

Integrin alphaIIbbeta3 plays a pivotal role in platelet aggregation by binding to fibrinogen. The beta3 cytoplasmic domain of alphaIIbbeta3 interacts with cytoskeletal and signaling proteins and is cleaved by micro -calpain, a calcium regulated cysteine protease. In the present study, we have investigated in more detail the cleavage of the beta3 cytoplasmic domain during platelet aggregation induced by thrombin, TRAP-1 and TRAP-4. Our data show that beta3 is cleaved in all three cases. The time course of beta3 cleavage and the amount of cleaved beta3 depends on the way platelets are activated and on the complete activation of micro -calpain, with a maximum of 90% of cleaved beta3 obtained when thrombin is used. Furthermore, our results also show that the cleaved alphaIIbbeta3 is mainly distributed in the Triton soluble fraction, indicating its inability to bind to the cytoskeleton. Interestingly, in the absence of GPIbalpha or following inhibition of thrombin binding to GPIbalpha, there is a reduction in the thrombin-induced calcium flux, beta3 cleavage and micro -calpain activation. These results suggest that cleavage of the beta3 cytoplasmic domain by micro -calpain might be an important step regulating the link between the cytoskeleton and alphaIIbbeta3 during platelet aggregation, and that GPIbalpha could function as a cofactor for the complete activation of platelets by thrombin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15045135     DOI: 10.1160/TH03-06-0391

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

Review 1.  Thrombin receptor antagonists for the treatment of atherothrombosis: therapeutic potential of vorapaxar and E-5555.

Authors:  Sergio Leonardi; Pierluigi Tricoci; Richard C Becker
Journal:  Drugs       Date:  2010-10-01       Impact factor: 9.546

2.  Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo.

Authors:  Grace M Thomas; Laurence Panicot-Dubois; Romaric Lacroix; Françoise Dignat-George; Dominique Lombardo; Christophe Dubois
Journal:  J Exp Med       Date:  2009-08-10       Impact factor: 14.307

3.  Disabled-2 is required for efficient hemostasis and platelet activation by thrombin in mice.

Authors:  Hui-Ju Tsai; Chien-Ling Huang; Yao-Wen Chang; Ding-Yuan Huang; Chung-Ching Lin; Jonathan A Cooper; Ju-Chien Cheng; Ching-Ping Tseng
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-09-11       Impact factor: 8.311

Review 4.  Calpain-mediated regulation of platelet signaling pathways.

Authors:  Shafi M Kuchay; Athar H Chishti
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.